T1	tradename 105 111	MEGACE
T3	tradename 176 182	MEGACE
T5	tradename 189 195	MEGACE
T7	activeingredient 200 217	megestrol acetate
T9	routeofadministration 224 228	Oral
T11	fdaapprovaldate 263 267	1993
T13	tradename 335 341	Megace
T15	routeofadministration 345 349	oral
T17	chemoclass 366 375	progestin
T19	indication 406 414	anorexia
T21	indication 416 424	cachexia
T23	indication 432 467	unexplained significant weight loss
T25	tradename 647 653	Megace
T27	routeofadministration 657 661	oral
T29	dose 676 682	625 mg
T31	frequency 682 686	/day
T33	frequency 692 696	/day
T35	frequency 713 719	daily)
T37	routeofadministration 819 823	Oral
T39	activeingredient 856 873	megestrol acetate
T41	activeingredient 985 1002	megestrol acetate
T43	activeingredient 1416 1434	megestrol acetate.
T45	activeingredient 1562 1579	megestrol acetate
T47	activeingredient 1867 1884	megestrol acetate
T49	routeofadministration 1885 1889	oral
T51	adversereaction 1942 1948	nausea
T53	adversereaction 1950 1958	diarrhea
T55	adversereaction 1960 1969	impotence
T57	adversereaction 1971 1975	rash
T59	adversereaction 1977 1987	flatulence
T61	adversereaction 1989 2001	hypertension
T63	adversereaction 2007 2015	asthenia
T65	company 2071 2089	Par Pharmaceutical
T67	company 2091 2095	Inc.
T69	co-administereddrug 2277 2286	indinavir
T71	co-administereddrug 2332 2341	indinavir
T73	activeingredient 2389 2406	megestrol acetate
T75	tradename 2866 2872	Megace
T77	routeofadministration 2876 2880	oral
T79	co-administereddrug 3435 3444	Indinavir
T81	co-administereddrug 3450 3460	Zidovudine
T83	co-administereddrug 3465 3474	Rifabutin
T85	tradename 4126 4132	Megace
T87	routeofadministration 4136 4140	oral
T89	indication 4186 4194	anorexia
T91	indication 4196 4204	cachexia
T93	indication 4212 4247	unexplained significant weight loss
T95	activeingredient 4387 4404	megestrol acetate
T97	indication 4409 4420	weight loss
T99	indication 4473 4484	weight loss
T101	activeingredient 4713 4730	Megestrol acetate
T103	indication 4777 4789	weight loss.
T105	tradename 4863 4869	Megace
T107	routeofadministration 4873 4877	oral
T109	dose 4892 4898	625 mg
T111	frequency 4898 4902	/day
T113	frequency 4908 4912	/day
T115	frequency 4929 4935	daily)
T117	tradename 5213 5219	Megace
T119	routeofadministration 5261 5265	oral
T121	activeingredient 5298 5315	megestrol acetate
T123	tradename 5325 5331	Megace
T125	activeingredient 5371 5388	megestrol acetate
T127	tradename 5392 5398	Megace
T129	routeofadministration 5399 5403	oral
T131	activeingredient 5435 5452	megestrol acetate
T133	routeofadministration 5453 5457	oral
T135	activeingredient 5560 5577	megestrol acetate
T137	activeingredient 5859 5876	Megestrol acetate
T139	activeingredient 6422 6439	megestrol acetate
T141	routeofadministration 6440 6444	oral
T143	activeingredient 6588 6606	megestrol acetate.
T145	activeingredient 6734 6751	megestrol acetate
T147	activeingredient 6977 6994	megestrol acetate
T149	tradename 7135 7141	Megace
T151	tradename 7674 7680	Megace
T153	activeingredient 8051 8069	megestrol acetate.
T155	tradename 8872 8878	Megace
T157	activeingredient 8883 8900	megestrol acetate
T159	routeofadministration 8901 8905	oral
T161	activeingredient 8959 8976	megestrol acetate
T163	routeofadministration 8977 8981	oral
T165	activeingredient 9204 9221	megestrol acetate
T167	routeofadministration 9222 9226	oral
T169	activeingredient 9500 9517	Megestrol Acetate
T171	adversereaction 9604 9612	Diarrhea
T173	adversereaction 9632 9641	Impotence
T175	adversereaction 9658 9662	Rash
T177	adversereaction 9679 9689	Flatulence
T179	adversereaction 9706 9718	Hypertension
T181	adversereaction 9734 9742	Asthenia
T183	adversereaction 9758 9766	Insomnia
T185	adversereaction 9782 9788	Nausea
T187	adversereaction 9804 9810	Anemia
T189	adversereaction 9847 9863	Libido Decreased
T191	adversereaction 9879 9888	Dyspepsia
T193	adversereaction 9904 9917	Hyperglycemia
T195	adversereaction 9933 9941	Headache
T197	adversereaction 9958 9962	Pain
T199	adversereaction 9978 9986	Vomiting
T201	adversereaction 10002 10011	Pneumonia
T203	adversereaction 10027 10044	Urinary Frequency
T205	activeingredient 10427 10444	megestrol acetate
T207	adversereaction 10500 10514	abdominal pain
T209	adversereaction 10516 10526	chest pain
T211	adversereaction 10528 10537	infection
T213	adversereaction 10539 10549	moniliasis
T215	adversereaction 10554 10561	sarcoma
T217	adversereaction 10587 10601	cardiomyopathy
T219	adversereaction 10606 10617	palpitation
T221	adversereaction 10638 10653	c onsti pa tion
T223	adversereaction 10655 10665	dr y mouth
T225	adversereaction 10667 10682	hepatome ga l y
T227	adversereaction 10684 10704	increased salivation
T229	adversereaction 10709 10724	oral moniliasis
T231	adversereaction 10795 10808	LDH increased
T233	adversereaction 10810 10815	edema
T235	adversereaction 10820 10836	peripheral edema
T237	adversereaction 10856 10867	paresthesia
T239	adversereaction 10869 10878	confusion
T241	adversereaction 10880 10890	convulsion
T243	adversereaction 10892 10902	depression
T245	adversereaction 10904 10914	neuropathy
T247	adversereaction 10916 10927	hypesthesia
T249	adversereaction 10932 10949	abnormal thinking
T251	adversereaction 10972 10979	dyspnea
T253	adversereaction 10981 10986	cough
T255	adversereaction 10988 10999	pharyngitis
T257	adversereaction 11004 11017	lung disorder
T259	adversereaction 11041 11049	alopecia
T261	adversereaction 11051 11057	herpes
T263	adversereaction 11059 11067	pruritus
T265	adversereaction 11069 11089	vesiculobullous rash
T267	adversereaction 11091 11099	sweating
T269	adversereaction 11104 11117	skin disorder
T271	adversereaction 11135 11144	amblyopia
T273	adversereaction 11166 11177	albuminuria
T275	adversereaction 11179 11199	urinary incontinence
T277	adversereaction 11201 11224	urinary tract infection
T279	adversereaction 11229 11242	gynecomastia.
T281	activeingredient 11313 11330	megestrol acetate
T283	routeofadministration 11331 11335	oral
T285	adversereaction 11355 11379	thromboembolic phenomena
T287	adversereaction 11390 11406	thrombophlebitis
T289	adversereaction 11408 11428	deep vein thrombosis
T291	adversereaction 11434 11452	pulmonary embolism
T293	adversereaction 11458 11477	glucose intolerance
T295	co-administereddrug 11547 11556	Indinavir
T297	co-administereddrug 11609 11618	indinavir
T299	activeingredient 11622 11639	megestrol acetate
T301	co-administereddrug 11676 11685	indinavir
T303	activeingredient 11733 11750	megestrol acetate
T305	co-administereddrug 11792 11802	Zidovudine
T307	co-administereddrug 11807 11816	Rifabutin
T309	co-administereddrug 11843 11853	zidovudine
T311	co-administereddrug 11858 11867	rifabutin
T313	activeingredient 11883 11900	megestrol acetate
T315	activeingredient 12206 12223	megestrol acetate
T317	tradename 12485 12491	Megace
T319	routeofadministration 12498 12502	oral
T321	activeingredient 12663 12680	megestrol acetate
T323	routeofadministration 12681 12685	oral
T325	indication 12717 12725	anorexia
T327	indication 12727 12735	cachexia
T329	indication 12743 12778	unexplained significant weight loss
T331	activeingredient 13317 13334	Megestrol acetate
T333	activeingredient 13672 13689	Megestrol acetate
T335	tradename 13802 13808	Megace
T337	chemoclass 13817 13829	progesterone
T339	activeingredient 13975 13992	megestrol acetate
T341	routeofadministration 13993 13997	oral
T343	dose 14044 14051	1200 mg
T345	frequency 14051 14056	/day.
T347	adversereaction 14201 14209	diarrhea
T349	adversereaction 14211 14217	nausea
T351	adversereaction 14219 14233	abdominal pain
T353	adversereaction 14235 14254	shortness of breath
T355	adversereaction 14256 14261	cough
T357	adversereaction 14263 14276	unsteady gait
T359	adversereaction 14278 14290	listlessness
T361	adversereaction 14296 14307	chest pain.
T363	tradename 14358 14364	Megace
T365	routeofadministration 14371 14375	oral
T367	activeingredient 14462 14479	Megestrol acetate
T369	tradename 14657 14663	Megace
T371	routeofadministration 14667 14671	oral
T373	activeingredient 14692 14709	megestrol acetate
T375	chemoclass 14778 14791	progesterone.
T377	activeingredient 14793 14810	Megestrol acetate
T379	molecularweight 15034 15041	384.52.
T381	tradename 15043 15049	Megace
T383	routeofadministration 15059 15063	oral
T385	activeingredient 15096 15113	megestrol acetate
T387	tradename 15122 15128	Megace
T389	routeofadministration 15132 15136	oral
T391	inactiveingredient 15193 15200	alcohol
T393	inactiveingredient 15229 15251	artificial lime flavor
T395	inactiveingredient 15253 15276	citric acid monohydrate
T397	inactiveingredient 15278 15293	docusate sodium
T399	inactiveingredient 15295 15339	hydroxypropyl methylcellulose (hypromellose)
T401	inactiveingredient 15341 15376	natural and artificial lemon flavor
T403	inactiveingredient 15378 15392	purified water
T405	inactiveingredient 15394 15409	sodium benzoate
T407	inactiveingredient 15411 15435	sodium citrate dihydrate
T409	inactiveingredient 15441 15449	sucrose.
T411	activeingredient 15578 15595	megestrol acetate
T413	indication 15619 15628	cachexia.
T415	activeingredient 15661 15678	megestrol acetate
T417	indication 15711 15719	cachexia
T419	activeingredient 15836 15853	megestrol acetate
T421	dose 15878 15884	625 mg
T423	tradename 15900 15906	Megace
T425	routeofadministration 15910 15914	oral
T427	dose 15965 15971	800 mg
T429	activeingredient 15986 16003	megestrol acetate
T431	routeofadministration 16004 16008	oral
T433	tradename 16097 16103	Megace
T435	activeingredient 16244 16261	megestrol acetate
T437	dose 16301 16307	150 mg
T439	dose 16312 16318	675 mg
T441	tradename 16325 16331	Megace
T443	dose 16601 16607	625 mg
T445	tradename 16608 16614	Megace
T447	activeingredient 16704 16721	megestrol acetate
T449	activeingredient 16798 16815	megestrol acetate
T451	tradename 16986 16992	Megace
T453	activeingredient 17077 17094	megestrol acetate
T455	indication 17218 17229	weight loss
T457	routeofadministration 17279 17283	oral
T459	dose 17293 17299	800 mg
T461	frequency 17299 17303	/day
T463	activeingredient 17307 17324	megestrol acetate
T465	routeofadministration 17325 17329	oral
T467	activeingredient 17378 17395	megestrol acetate
T469	cmax 17400 17416	753 (539) ng/mL.
T471	auc 17435 17462	10476 ( 7788) ng x hr/mL.
T473	tmax 17485 17496	five hours.
T475	dose 17596 17602	750 mg
T477	activeingredient 17606 17623	megestrol acetate
T479	routeofadministration 17624 17628	oral
T481	cmax 17684 17699	490 (238) ng/mL
T483	auc 17704 17726	6779 (3048) hr x ng/mL
T485	tmax 17769 17781	three hours.
T487	activeingredient 17972 17989	megestrol acetate
T489	dose 18029 18039	4 to 90 mg
T491	activeingredient 18259 18276	Megestrol acetate
T493	eliminationhalflife 18577 18591	20 to 50 hours
T495	activeingredient 18661 18678	megestrol acetate
T497	co-administereddrug 18825 18834	indinavir
T499	co-administereddrug 18836 18846	zidovudine
T501	co-administereddrug 18850 18859	rifabutin
T503	activeingredient 18887 18904	megestrol acetate
T505	co-administereddrug 18925 18935	Zidovudine
T507	co-administereddrug 19023 19033	zidovudine
T509	activeingredient 19039 19056	megestrol acetate
T511	co-administereddrug 19091 19100	Rifabutin
T513	co-administereddrug 19188 19197	rifabutin
T515	activeingredient 19203 19220	megestrol acetate
T517	co-administereddrug 19255 19264	Indinavir
T519	activeingredient 19353 19370	megestrol acetate
T521	dose 19372 19378	675 mg
T523	co-administereddrug 19396 19405	indinavir
T525	dose 19419 19426	800 mg)
T527	co-administereddrug 19531 19541	indinavir.
T529	activeingredient 19729 19746	megestrol acetate
T531	dose 19810 19820	13.3 mg/kg
T533	frequency 19820 19825	/day)
T535	activeingredient 19917 19934	megestrol acetate
T537	dose 19936 19940	0.01
T539	dose 19942 19959	0.1 or 0.25 mg/kg
T541	frequency 19959 19964	/day)
T543	dose 20130 20134	0.01
T545	dose 20136 20152	0.1 or 0.5 mg/kg
T547	frequency 20152 20156	/day
T549	activeingredient 20157 20175	megestrol acetate.
T551	dose 20236 20251	3.9 or 10 mg/kg
T553	frequency 20251 20255	/day
T555	activeingredient 20259 20276	megestrol acetate
T557	tradename 20443 20449	Megace
T559	routeofadministration 20453 20457	oral
T561	activeingredient 20514 20531	Megestrol acetate
T563	dose 20808 20830	16.25 and 32.50 mg/kg.
T565	dose 20963 20973	13.3 mg/kg
T567	frequency 20973 20978	/day)
T569	activeingredient 21076 21101	megestrol acetate-treated
T571	tradename 21353 21359	Megace
T573	activeingredient 21604 21621	megestrol acetate
T575	tradename 21680 21686	Megace
T577	activeingredient 21694 21711	megestrol acetate
T579	routeofadministration 21712 21716	oral
T581	activeingredient 21767 21784	megestrol acetate
T583	routeofadministration 21785 21789	oral
T585	activeingredient 21947 21964	megestrol acetate
T587	dose 21982 21988	100 mg
T589	dose 21990 21996	400 mg
T591	dose 22002 22008	800 mg
T593	frequency 22009 22016	per day
T595	indication 22054 22071	anorexia/cachexia
T597	indication 22076 22100	significant weight loss.
T599	dose 22488 22494	800 mg
T601	dose 22505 22511	400 mg
T603	dose 22651 22657	800 mg
T605	dose 22690 22696	400 mg
T607	dose 22720 22726	100 mg
T609	dose 23203 23209	800 mg
T611	dose 23227 23233	400 mg
T613	dose 23254 23260	100 mg
T615	dose 23452 23458	800 mg
T617	dose 23742 23748	800 mg
T619	activeingredient 24116 24133	megestrol acetate
T621	dose 24134 24140	800 mg
T623	frequency 24140 24144	/day
T625	indication 24182 24199	anorexia/cachexia
T627	indication 24204 24228	significant weight loss.
T629	dose 24495 24501	800 mg
T631	activeingredient 25981 25998	Megestrol Acetate
T633	routeofadministration 25999 26003	Oral
T635	activeingredient 26127 26144	Megestrol Acetate
T637	tradename 26978 26984	Megace
T639	routeofadministration 26988 26992	oral
T641	routeofadministration 27042 27046	oral
T643	activeingredient 27079 27096	megestrol acetate
T645	tradename 27187 27193	Megace
T647	routeofadministration 27197 27201	oral
T649	activeingredient 27807 27825	megestrol acetate.
T651	tradename 27859 27865	Megace
T653	tradename 27965 27971	Megace
T655	tradename 28080 28086	Megace
T657	activeingredient 28143 28160	megestrol acetate
T659	tradename 28164 28170	Megace
T661	routeofadministration 28171 28175	oral
T663	activeingredient 28207 28224	megestrol acetate
T665	routeofadministration 28225 28229	oral
T667	tradename 28244 28250	Megace
T669	activeingredient 28273 28290	megestrol acetate
T671	tradename 28319 28330	Megace oral
T673	activeingredient 28352 28369	megestrol acetate
T675	routeofadministration 28370 28374	oral
T677	company 28686 28714	PAR PHARMACEUTICAL COMPANIES
T679	company 28716 28720	INC.
T681	u.s.patent 28770 28771	6
T683	u.s.patent 28772 28775	592
T685	u.s.patent 28776 28781	903 7
T687	u.s.patent 28782 28785	101
T689	u.s.patent 28786 28789	576
T691	tradename 28822 28828	Megace
T693	company 28858 28886	Bristol-Myers Squibb Company
T695	company 28899 28917	Par Pharmaceutical
T697	company 28919 28923	Inc.
